ABT 560Alternative Names: ABT-560; ABT-PR2
Latest Information Update: 05 Feb 2013
At a glance
- Originator NeuroSearch
- Developer Abbott Laboratories
- Mechanism of Action Alpha4beta2 nicotinic receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- Available For Licensing Yes
Highest Development Phases
- Discontinued Cognition disorders